DOXAZOSIN LOWERS BLOOD-PRESSURE AND IMPROVES INSULIN RESPONSES TO A GLUCOSE-LOAD WITH NO CHANGES IN TYROSINE KINASE-ACTIVITY OR INSULIN BINDING

被引：10

作者：

DOMINGUEZ, LJ ^{[1
]}

WEINBERGER, MH ^{[1
]}

CEFALU, WT ^{[1
]}

JACOBS, DB ^{[1
]}

BARBAGALLO, M ^{[1
]}

WALSH, MF ^{[1
]}

SOWERS, JR ^{[1
]}

机构：

[1] WAYNE STATE UNIV,DIV ENDOCRINOL,DETROIT,MI

来源：

AMERICAN JOURNAL OF HYPERTENSION | 1995年 / 8卷 / 05期

关键词：

DOXAZOSIN; HYPERTENSION; INSULIN; NONINSULIN-DEPENDENT DIABETES MELLITUS; TYROSINE KINASE ACTIVITY; INSULIN BINDING;

D O I：

10.1016/0895-7061(95)00054-S

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

alpha-Adrenergic blockers have shown favorable metabolic effects. We evaluated the glucose and insulin responses to a glucose load and lipid profiles in 36 diabetic hypertensive patients before and after 8 weeks of doxazosin administration. To evaluate insulin action at the cellular level, erythrocyte insulin binding and tyrosine kinase (TK) activity were measured in 12 of these patients. Systolic and diastolic blood pressures decreased significantly (P < .0001) after 8 weeks of doxazosin therapy. Doxazosin administration significantly reduced the integrated insulin response (area under the curve [AUC]-insulin: 6093 +/- 894 to 5260 +/- 807; P = .04) and the insulin/glucose index (I/G) at 90 and 120 min after a glucose load (at 90 min, 0.230 +/- 0.055 v 0.180 +/- 0.04, P < .05; at 120 min, 0.275 +/- 0.071 v 0.173 +/- 0.036, P < .05). HDL, level increased from 31.1 +/- 1.5 mg% to 34 +/- 1.6 mg% (P < .05) after doxazosin. Erythrocyte insulin binding and tyrosine kinase activity were not significantly altered after doxazosin. No significant correlation was found between the insulin or glucose responses and the insulin receptor binding or tyrosine kinase activity before and after treatment.

引用

页码：528 / 532

页数：5

共 19 条

[1]

Ferrannini, Buzzigoli, Bonadonna, Et al., Insulin resistance in essential hypertension, N Engl J Med, 317, pp. 350-357, (1987)

[2]

Epstein, Sowers, Diabetes mellitus and hypertension, Hypertension, 20, pp. 403-418, (1992)

[3]

Standley, Ram, Sowers, Insulin attenuation of vascular smooth muscle calcium responses in Zucker lean and obese rats, Endocrinology, 133, pp. 1693-1699, (1993)

[4]

Julius, Gudbrandsson, Early association of sympathetic overactivity, hypertension insulin resistance and coronary risk, J Cardiovasc Pharmacol, 20, pp. S40-S48, (1992)

[5]

Barbagallo, Gupta, Resnick, Cellular ionic effects of insulin in normal human erythrocytes: a nuclear magnetic resonance study, Diabetologia, 36, pp. 146-149, (1993)

[6]

Black, The coronary artery paradox: the role of hyperinsulinemia and insulin resistance and implications for therapy, J Cardiovasc Pharmacol, 15, pp. S26-S38, (1990)

[7]

Macphee, Curzio, Farish, Et al., Placebo-controlled trial of doxazosin in management of patients with hypertension and hypercholesterolemia, J Cardiovasc Pharmacol, 20, pp. 429-433, (1992)

[8]

Neaton, Grimm, Prineas, Et al., Treatment of mild hypertension study: final results, JAMA, 270, pp. 713-724, (1993)

[9]

Lehtonen, Lowered levels of serum insulin, glucose and cholesterol in hypertensive patients during treatment with doxazosin, Curr Ther Res, 47, pp. 278-284, (1990)

[10]

Shieh, Sheu, Fuh, Et al., Glucose, insulin and lipid metabolism in doxazosin-treated patients with hypertension, Am J Hypertens, 5, pp. 827-831, (1992)

← 1 2 →